Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1935 of 5804
-
New drug shows promise for liver disease in early trial
Disease control CompletedThis was a Phase 2a, multi-center, placebo-controlled study in which patients with autoimmune hepatitis received zetomipzomib or placebo in addition to standard-of-care for 24 weeks; an optional open-label extension period allowed participants to receive zetomipzomib (KZR-616) fo…
Phase: PHASE2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Can a common arthritis drug help stop vitiligo from spreading?
Disease control CompletedThis is a phase 2, randomized, double blind, multicenter study evaluating the efficacy and safety of the combination of methotrexate plus UVB TL01 in vitiligo.
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Oxygen for fetal distress: helpful or just hot air?
Knowledge-focused Recruiting nowMore than 80% of the 3 million women who labor and deliver each year in the United States undergo continuous electronic fetal monitoring (EFM) during labor in order to fetal hypoxia and prevent the transition to acidemia, expedited operative delivery, and/or neonatal morbidity. C…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Can an allergy drug help fatty liver? new study says maybe
Disease control CompletedThe aim of this study is to investigate the safety and efficacy of using ketotifen in patients with NAFLD patients without cirrhosis
Phase: PHASE4 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New IVF drug combo shows promise for better embryos
Disease control CompletedFollitropin delta is a rFSH, uniquely expressed in a human fetal retinal cell line, which owing to differences in glycosylation profile has a lower clearance and induces a higher ovarian response in humans than existing rFSH preparations when administered at equal doses of biolog…
Sponsor: Clinique Ovo • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Blood test may uncover hidden cancers in nerve disorder patients
Knowledge-focused Recruiting nowThe main objective of the study is to assess whether circulating tumor cells (CTCs) can be detected in the peripheral blood of patients with paraneoplastic neurological syndromes (PNS) by diagnostic leukapheresis (DLA) combined with the CELLSEARCH® System during clinical routine …
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Sound waves could unlock the minds of Brain-Injured patients
Knowledge-focused CompletedDisorders of consciousness (DOC) diagnosis suffers from the difficulty to measure the level of consciousness due to the variability associated with behavioural assessments and the difficulty in detecting the residual level of consciousness in patients who do not show any behaviou…
Phase: NA • Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New scan could predict rectal cancer treatment success early
Knowledge-focused Recruiting nowWith 50 patients included, this trial would be the largest pilot study evaluating the value of MRI PET in locally advanced rectal cancer. On the other hand, it would be the only pilot study performing several MRI PET during neoadjuvant treatment. Presumably, the response assessed…
Sponsor: Centre Paul Strauss • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple pill replace IV drips for bleeding ulcers?
Disease control Recruiting nowVonoprazan (VPZ), an oral potassium-competitive acid blocker (P-CAB) has emerged as an alternative potent acid-suppressant.It has a faster onset of action in 1 day (3-5 days in PPI), and is more stable in acidic condition than PPI. While many studies compared Vonoprazan against P…
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Cash and coaching: a recipe to fight malnutrition?
Prevention CompletedThis trial studied different combinations of cash assistance to families that live in food insecure areas of Somalia and aimed to understand if this cash assistance provided reduced malnutrition of children and mothers.
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 26, 2026 14:48 UTC
-
Pharmacy navigators boost HIV prevention in kenyan teens
Prevention OngoingThe investigators will conduct a cluster RCT in Kisumu, Kenya to determine the effect of nurse-navigators on PrEP initiation, persistence, and adherence among AGYW seeking contraception within a pharmacy-based PrEP delivery model. The study will randomize 20 retail pharmacies off…
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
Community weight loss program shows promise for older black women
Disease control CompletedThe first phase of the study is a feasibility survey of eligible participants, completed prior to initiating the intervention. The intervention consists of a 6-month 1:1 randomized trial with a waitlist control that recruits 120 older AA women. The rationale for these aims is tha…
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New DNA scanner could spot hidden cancer clues
Knowledge-focused Recruiting nowStandard cytogenetics (CBA +/- FISH) is of diagnostic and prognostic interest in Ph- MPN. However, its value is limited by the low frequency of detected abnormalities. The development of tools to increase the sensitivity of detection of chromosomal alterations is therefore partic…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Could a simple additive make nerve blocks last longer after chest surgery?
Symptom relief Recruiting nowPostoperative pain management is considered an integral part of perioperative care in patients undergoing thoracotomy. In order to reduce these complications, multiple regional techniques have been developed for thoracotomy including Intercostal nerve block, Erectospinae plane bl…
Phase: NA • Sponsor: National Cancer Institute, Egypt • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Experimental NK cell therapy for blood cancers hits early hurdle
Disease control TerminatedThis is a first-in-human (FIH) Phase 1/Phase 2 study for evaluating SAR445514 in monotherapy in participants with relapsed/refractory multiple myeloma (RRMM) and relapsed/refractory light chain amyloidosis (RRLCA). The study will comprise 3 parts: A dose escalation phase (Part …
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a device ease Post-Stroke pain without pills?
Symptom relief Recruiting nowThe Investigators will enroll patients who have had a stroke and are experiencing post-stroke pain secondary to their infarct and disruption of the sensory system in a research study to compare the effectiveness of Scrambler Therapy to traditional pharmacologic therapies.
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Can smartphone apps help more people quit smoking? new study tests three approaches.
Disease control Recruiting nowThis study will evaluate the comparative effectiveness of three smoking cessation therapies: mobile health (mHealth) application iCanQuit, mHealth application iCanQuit + Motiv8, and the Florida quit line.
Phase: NA • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug combo tested for tough bile duct cancers
Disease control TerminatedThe goal of this clinical trial is to test a new drug plus standard treatment compared with standard treatment alone in patients with previously untreated cholangiocarcinoma or those that have progressed after first-line treatment for cholangiocarcinoma. The main questions it ai…
Phase: PHASE2 • Sponsor: Lisata Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Less botox, same relief? new study tests lower dose for bladder leaks in women over 70
Symptom relief OngoingThe purpose of this study is to study the treatment of urgency urinary incontinence (UUI), specifically among women 70 years and older, by comparing reduced versus standard dose of onabotulinumtoxinA (BTX; trade name BOTOX(c)) injection in the bladder.
Phase: PHASE1, PHASE2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New drug combo targets tough tumors
Disease control OngoingThe goals of this clinical study are to identify if GS-4528 alone or in combination with anti-programmed cell death protein 1 (PD-1) (Anti-PD-1) Monoclonal Antibody is safe and tolerable in people with solid tumors and to identify the recommended dose of GS-4528 for further devel…
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC